ZBD-2 significantly attenuated the symptoms of chronic SCI-pain and pain-induced depressive-like behaviors. ZBD-2 inhibited the decreases in the expression of synaptic plasticity-related signaling proteins. ZBD-2 reversed chronic, SCI-induced gliocyte activation at the lesion site.